** BofA Global Research downgrades health insurer Centene CNC.N to "underperform" from "neutral", trims PT to $30 from $52
** Medicaid and Affordable Care Act $(ACA)$ exchange markets are slowing due to the new Reconciliation Bill, and there's a strong chance that enhanced government subsidies for ACA coverage will expire after 2025, BofA analysts say
** Brokerage expects at least $2.75 per share of pressure from the ACA exchanges, plus higher costs in Medicaid
** Membership declines driven by the new legislation are expected to slow CNC’s revenue growth through 2029, while shifting insurance risks and potential Medicaid rate cuts will make it more difficult for the company to restore normal profit margins, BofA analysts say
** As of last close, CNC stock down 50.5% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。